Evaluation of a Predictive Model of Individual Chance for Sustained Virological Response in Patients with Chronic Hepatitis C Treated with Peginterferon Alfa-2a and Ribavirin

被引：0
|
作者：
Mauss, Stefan
Hueppe, Dietrich
Zehnter, Elmar
Richter, Swantje
Tappe, Andre
Hermann, Eva
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A840 / A840
页数：1
相关论文
共 50 条
  • [31] Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response
    Howell, CD
    Jeffers, LS
    Cassidy, W
    Reddy, KR
    Hu, S
    Lee, JS
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (06) : 371 - 376
  • [32] A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirin
    Ferenci, Peter
    Aires, Rodrigo
    Ancuta, Ioan
    Arohnson, Andrew
    Cheinquer, Hugo
    Delic, Dragan
    Gschwantler, Michael
    Larrey, Dominique
    Tallarico, Ludovico
    Schmitz, Manuela
    Tatsch, Fernando
    Ouzan, Denis
    LIVER INTERNATIONAL, 2014, 34 (10) : 1550 - 1559
  • [33] Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
    Heathcote, EJ
    Shiffman, ML
    Cooksley, WGE
    Dusheiko, GM
    Lee, SS
    Balart, L
    Reindollar, R
    Reddy, RK
    Wright, TL
    Lin, A
    Hoffman, J
    De Pamphilis, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23): : 1673 - 1680
  • [34] A comparison of sustained viral response in patients with chronic hepatitis C virus (HCV) treated with peginterferon alfa-2a (Peg2a) versus peginterferon alfa-2b (Peg2b) and ribavirin
    Poordad, F
    Tran, TT
    Ayoub, W
    Patel, Y
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S130 - S130
  • [35] Impact of Asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C
    Missiha, Sharif
    Heathcote, Jenny
    Arenovich, Tamara
    Khan, Kamran
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (10): : 2181 - 2188
  • [36] Treatment of patients with chronic hepatitis C with peginterferon alfa-2a (40KD) (Pegasys®) alone or in combination with ribavirin results in long-lasting sustained virological response.
    Swain, M
    Lai, MY
    Shiffmann, ML
    Cooksley, WGE
    Abergel, A
    Diago, M
    Brunda, M
    HEPATOLOGY, 2002, 36 (04) : 598A - 598A
  • [37] Cytokines predict virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy
    Fu, Wen-Kang
    Cao, Jie
    Mi, Ning-Ning
    Huang, Chong-Fei
    Gao, Long
    Zhang, Jin-Duo
    Yue, Ping
    Bai, Bing
    Lin, Yan-Yan
    Meng, Wen-Bo
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (11) : 2255 - 2265
  • [38] Cytokines predict virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy
    Wen-Kang Fu
    Jie Cao
    Ning-Ning Mi
    Chong-Fei Huang
    Long Gao
    Jin-Duo Zhang
    Ping Yue
    Bing Bai
    Yan-Yan Lin
    Wen-Bo Meng
    World Journal of Clinical Cases, 2020, 8 (11) : 2255 - 2265
  • [39] Impact of Asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C
    Missiha, SB
    Heathcote, EJ
    Arenovich, T
    Khan, K
    GASTROENTEROLOGY, 2005, 128 (04) : A683 - A684
  • [40] A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2α/Ribavirin
    Asselah, Tarik
    Thompson, Alex J.
    Flisiak, Robert
    Romero-Gomez, Manuel
    Messinger, Diethelm
    Bakalos, Georgios
    Shiffman, Mitchell L.
    PLOS ONE, 2016, 11 (03):
12345